These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 25185875

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of Depression on Health and Medical Care Utilization and Expenses in US Adults With Migraine: A Retrospective Cross Sectional Study.
    Wu J, Davis-Ajami ML, Kevin Lu Z.
    Headache; 2016 Jul; 56(7):1147-60. PubMed ID: 27350407
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study.
    Bigal ME, Buse DC, Chen YT, Golden W, Serrano D, Chu MK, Lipton RB.
    Headache; 2010 Oct; 50(9):1440-8. PubMed ID: 20533956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people.
    Braunstein D, Donnet A, Pradel V, Sciortino V, Allaria-Lapierre V, Lantéri-Minet M, Micallef J.
    Cephalalgia; 2015 Nov; 35(13):1172-80. PubMed ID: 25667299
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Access to Triptans for Acute Episodic Migraine: A Qualitative Study.
    Khan S, Mascarenhas A, Moore JE, Knowles S, Gomes T.
    Headache; 2015 Nov; 55 Suppl 4():199-211. PubMed ID: 26178420
    [Abstract] [Full Text] [Related]

  • 13. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK.
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [Abstract] [Full Text] [Related]

  • 14. Triptans: low utilization and high turnover in the general population.
    Panconesi A, Pavone E, Franchini M, Mennuti N, Bartolozzi M, Guidi L, Banfi R.
    Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
    [Abstract] [Full Text] [Related]

  • 15. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [Abstract] [Full Text] [Related]

  • 16. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
    Ng-Mak DS, Chen YT, Ho TW, Stanford B, Roset M.
    Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
    [Abstract] [Full Text] [Related]

  • 17. Examining the interrelationship of migraine onset, duration, and time to treatment.
    Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS.
    Headache; 2012 Mar; 52(3):363-73. PubMed ID: 22077159
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identifying the factors underlying discontinuation of triptans.
    Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ.
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [Abstract] [Full Text] [Related]

  • 20. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P, Sporrong SK, Ljunggren G, Wettermark B, von Euler M.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.